Alimera Sciences Announces Second Quarter 2016 Financial Results and Provides Business Update
Strong revenue gains in the second quarter of 2016 U.S. ILUVIEN volume significantly increased Over 6,000 eyes treated with ILUVIEN to date Positive discussions with the FDA regarding future potential indications for ILUVIEN ATLANTA, Aug. 03, 2016 (GLOBE …